Reversibility test in the early stages of bronchial asthma

Journal of Asthma

Volumn 42, Issue 6, 2005, Pages 487-491

  Mariotta, Salvatore ^a,b   Sposato, Bruno ^a   Ricci, Alberto ^a   Bruno, Pierdonato ^a   Aquilini, Mauro ^a   Mannino, Francesco ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Airway obstruction; Bronchial asthma; Diagnosis; 2 agonists

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; SALBUTAMOL;

ADULT; AIRWAY OBSTRUCTION; ARTICLE; ASTHMA; CLINICAL ARTICLE; DIAGNOSTIC TEST; FEMALE; FORCED EXPIRATORY FLOW; FORCED EXPIRATORY VOLUME; HUMAN; LUNG FUNCTION TEST; MALE; METERED DOSE INHALER; PEAK EXPIRATORY FLOW; RELIABILITY; REVERSIBILITY TEST;

EID: 26944469551     PISSN: 02770903     EISSN: 15324303     Source Type: Journal    
DOI: 10.1081/JAS-200067536     Document Type: Article

References (22)

1. Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention. Washington, DC: National Heart, Lung and Blood Institute, 2002, (publication no. 02-3659).
2. American Thoracic Society. Lung function testing: selection of reference values and interpretative strategies. Am Rev Respir Dis 1991; 144:1202-1218.
3. Quanjer PH, Tammeling GJ, Cotes FE, Pedersen OF, Peslin R, Yernault JC. Standardized lung function testing. Eur Respir J 1993; 6(suppl 16):1-99.
4. Barnes PJ. Poorly perceived asthma. Thorax 1992; 47:408-409.
5. Bijl-Hofland ID, Cloostermann SG, Fogering HT, Akkermans RP, van Schayck CP. Relation of the perception of airway obstruction to the severity of asthma. Thorax 1999; 54:15-19.
6. Alcock SM, Mamun M, Prescott RJ, Connoly CK. Symptoms and pulmonary function in asthma. Respir Med 1998; 92:849-857.
7. Quanjer PH, Dalhuijsen A, Van Zomeren BC. Summary equations of reference values. Bull Eur Physiopathol Respir 1983; 19(suppl 5):45-51.
8. Quanjer PH, Lebowitz MD, Gregg I, Miller MR, Pedersen OF. Peak expiratory flow: conclusions and recommendations of a Working party of the European Respiratory Society. Eur Respir J 1997; 24(suppl):2S-8S.
9. Lorber DB, Kaltenborn W, Burrows B. Responses to isoproterenol in a general population sample. Am Rev Respir Dis 1978; 118:855-861.
10. Shim C. Response to bronchodilators. Clin Chest Med 1989; 10:155-164.
11. Glantz AS. Primer of Biostatistics. New York: McGraw Hill Inc., 1997.
12. British Thoracic Society Scottish Intercollegiate Guidelines Network. British guideline on the management of asthma. Thorax 2003; 58(Suppl 1):1-94.
13. Zomeren BC. Changing relationship between stature and lung volume during puberty. Respir Physiol 1986; 65:139-153.
14. Bjermer L. History and future perspectives of treating asthma as a systemic and small airways disease. Respir Med 2001; 95:703-719.
15. Wagner EM, Liu MC, Weinmann GG, Permutt S, Bleecker ER. Peripheral lung resistance in normal and asthmatic subjects. Am Rev Respir Dis 1990; 141:584-588.
16. Hamid Q, Song Y, Kotsimbos TC, Minshall E, Bair TR, Hegele RG, Hogg JC. Inflammation of small airways in asthma. J Allergy Clin Immunol 1997; 100:44-51.
17. Noah MS, Kabiray MM, Abdullah AK, Zaman AU. Measurement of reversibility of airways obstruction: which parameters use? Respiration 1985; 48:24-28.
18. Reed CE. The natural history of asthma in adults: the problem of irreversibility. J Allergy Clin Immunol 1999; 103:539-547.
19. Turcotte H, Boulet LP. Perception of breathlessness during early and late asthmatic responses. Am Rev Respir Dis 1993; 148:514-518.
20. Vignola AM, Chanez P, Campbell AM, Souques F, Lebel B, Enander I, Bousquet J. Airway inflammation in mild intermittent and in persistent asthma. Am J Respir Crit Care Med 1998; 157:403-409.
21. Louis R, Lau LC, Bron AO, Roldaan AC, Radermecker M, Djukanovic R. The relationship between airways inflammation and asthma severity. Am J Respir Crit Care Med 2000; 161:9-16.
22. Redington AE. Step one for asthma treatment: beta2-agonists or inhaled corticosteroid? Drugs 2001; 61:1231-1238.